Naproxeno Generis (Naproxen)

Naproxen blocks the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin levels, it reduces pain signaling, diminishes inflammatory swelling, and helps reset the hypothalamic temperature set‑point, providing analgesic, anti‑inflammatory, and antipyretic effects.

The specific dose of Naproxeno Generis is determined by the prescribing clinician based on the patient’s condition, age, renal and hepatic function, and concomitant therapies. Healthcare providers set the appropriate strength, frequency, and duration according to clinical guidelines and individual patient needs.

Naproxen is generally avoided in the third trimester of pregnancy because it may affect fetal cardiovascular function. Safety in early pregnancy and during lactation is not well established, so clinicians weigh potential benefits against risks and consider alternative therapies when possible.

To request Naproxeno Generis, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Both naproxen and ibuprofen are NSAIDs that inhibit COX enzymes, but naproxen has a longer half‑life, allowing less frequent dosing, and may provide more sustained pain control. Ibuprofen often has a slightly lower risk of gastrointestinal irritation, while naproxen may carry a higher cardiovascular risk in long‑term use. Choice depends on patient‑specific factors and clinician judgment.

Naproxeno Generis should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and sources of heat to maintain stability and potency throughout its shelf life.

Naproxeno Generis is taken orally, usually with a full glass of water. It can be taken with or without food; however, taking it with meals may reduce gastrointestinal discomfort. Patients should follow the dosing schedule prescribed by their healthcare professional.

The most serious risks include gastrointestinal bleeding or ulcer perforation, cardiovascular events such as heart attack or stroke, severe skin reactions (e.g., Stevens‑Johnson syndrome), and renal impairment. Patients should be monitored for signs of these events, especially if they have pre‑existing risk factors.

Naproxeno Generis should be avoided in individuals with known hypersensitivity to naproxen or other NSAIDs, active gastrointestinal ulceration or bleeding, severe heart failure, uncontrolled hypertension, and in the third trimester of pregnancy. It is also contraindicated in patients with significant renal or hepatic impairment unless specifically directed by a physician.